Breaking News, Financial News

Financial Report: AMRI

Contract revenue up 16% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 3Q Revenues: $60.8 million (+9%) 3Q Earnings: $3.9 million (loss of $2.1 million 3Q12) YTD Revenues: $179.5 million (+13%) YTD Earnings: $8.2 million (loss of $5.7 million YTD12) Comments: Total contract revenue in the quarter was $53.0 million, up 16% and includes AMRI’s Discovery Services ($10.4 million, +17%), Development and Small Scale Manufacturing ($9.0 million, +22%), and Large Scale Manufacturing ($33.6 million, +15%). Royalty revenue in the quarter was $7.7 million, dow...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters